Skip to main content
HairCited

Minoxidil untuk Kerontokan Rambut Pola Wanita

A

Berdasarkan 67 studi (4 meta-analyses, 11 RCTs) dengan 28,815 peserta secara total. 53/67 studi menunjukkan efek positif.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Kesimpulan

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efek: None None

Populasi: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Efek: None None

Populasi: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Efek: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Efek: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Efek: None None

Key Statistics

111

Studi

37800

Peserta

Positive

A

Peringkat

Referenced Papers

Australian prescriber 2025 2 sitasi
Annals of dermatology 2025
SAGE open medical … 2024 3 sitasi
Drugs 2023 221 sitasi
Anais brasileiros de … 2023 29 sitasi
Journal of cosmetic … 2023 3 sitasi
The Journal of … 2022 170 sitasi
Faculty reviews 2022 44 sitasi
Journal of cosmetic … 2022 7 sitasi
Journal of the … 2021 42 sitasi
American journal of … 2020 127 sitasi
International journal of … 2020 58 sitasi
Indian dermatology online … 2020 31 sitasi
Actas dermo-sifiliograficas 2019 5 sitasi
Australian journal of … 2018 8 sitasi
JAMA dermatology 2017 121 sitasi
The Cochrane database … 2016 18 sitasi
World journal of … 2015 62 sitasi
Seminars in cutaneous … 2015 20 sitasi
Clinical obstetrics and … 2015 9 sitasi
Current problems in … 2015 8 sitasi
Skin therapy letter 2014 29 sitasi
Dermatologic clinics 2013 78 sitasi
International journal of … 2013 61 sitasi
Indian journal of … 2013 16 sitasi
International journal of … 2013
The Cochrane database … 2012 15 sitasi
Skinmed 2012 5 sitasi
Seminars in cutaneous … 2009 4 sitasi
American family physician 2009
Journal of the … 2008 290 sitasi
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
The British journal … 2005 205 sitasi
The journal of … 2003 102 sitasi
Clinical and experimental … 2002 61 sitasi
Therapeutische Umschau. Revue … 2002 4 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

topical:
2-5% solution, twice daily

Batas atas: 5% topical solution

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

Waktu terbaik diminum: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interaksi yang Diketahui

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Asupan atas yang dapat ditoleransi: 5% topical solution

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Minoxidil help with Kerontokan Rambut Pola Wanita?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Kerontokan Rambut Pola Wanita management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Kerontokan Rambut Pola Wanita?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Kerontokan Rambut Pola Wanita?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.